2024-11-15 18:26:40
Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab as the First-line Treatment for Patients with NSCLC at Annual Meeting of the Chinese Society of Clinical Oncology
Health/ 2023-07-22
Innovent Presents Clinical Data of Anti-...

SUZHOU,China,Sept. 20,2018--Innovent Biologics (Innovent),a world-class China-based biopharmaceutical company that develops and commercializ...

St. Jude Children's Research Hospital and Tessa Therapeutics Announce Strategic Collaboration
Health/ 2023-07-22
St. Jude Children's Research Hospit...

The collaboration between St. Jude and Tessa aims to advance cellular immunotherapy treatments for childhood cancer

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release